|
WO2012018687A1
(en)
*
|
2010-08-02 |
2012-02-09 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
DE08786222T1
(de)
*
|
2007-07-31 |
2010-11-25 |
Affibody Ab |
Neue albuminbindende zusammensetzungen, verfahren und anwendungen
|
|
US20120134984A1
(en)
*
|
2009-06-01 |
2012-05-31 |
Olga Lubman |
Molecules with extended half-lives and uses thereof
|
|
EP2544785B1
(en)
*
|
2010-03-08 |
2015-09-30 |
GE Healthcare Bio-Sciences AB |
Immunoglobulin g fc region binding polypeptide
|
|
AU2011245980A1
(en)
*
|
2010-04-30 |
2012-11-08 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
|
|
CN110437321A
(zh)
*
|
2010-07-09 |
2019-11-12 |
阿菲博迪公司 |
多肽
|
|
EA024507B1
(ru)
|
2010-09-28 |
2016-09-30 |
Амилин Фармасьютикалс, Ллк |
Хорошо растворимые лептины
|
|
EP3028720A1
(en)
|
2010-09-28 |
2016-06-08 |
Amylin Pharmaceuticals, LLC |
Engineered polypeptides having enhanced duration of action
|
|
US9221892B2
(en)
|
2010-11-26 |
2015-12-29 |
Molecular Partners Ag |
Capping modules for designed ankyrin repeat proteins
|
|
WO2012162068A2
(en)
*
|
2011-05-21 |
2012-11-29 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use for extending serum half-life
|
|
CN104271588B
(zh)
|
2011-07-08 |
2017-10-10 |
安米林药品有限责任公司 |
具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
|
|
DK2729160T3
(da)
|
2011-07-08 |
2019-07-01 |
Aegerion Pharmaceuticals Inc |
Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet
|
|
WO2013126006A1
(en)
|
2012-02-20 |
2013-08-29 |
Swedish Orphan Biovitrum Ab (Publ) |
Polypeptides binding to human complement c5
|
|
JP2015512902A
(ja)
*
|
2012-03-28 |
2015-04-30 |
アフィボディ・アーベー |
経口投与
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
US20150133373A1
(en)
*
|
2012-03-28 |
2015-05-14 |
Amylin Pharmaceuticals, Llc |
Transmucosal delivery of engineered polypeptides
|
|
CN104470944B
(zh)
|
2012-05-25 |
2021-09-14 |
詹森生物科技公司 |
非天然共有白蛋白结合结构域
|
|
JP6590695B2
(ja)
*
|
2012-09-25 |
2019-10-16 |
アフィボディ・アーベー |
アルブミン結合ポリペプチド
|
|
KR102191655B1
(ko)
|
2012-10-05 |
2020-12-16 |
애피바디 에이비 |
Her3 결합 폴리펩티드
|
|
KR102151289B1
(ko)
*
|
2012-10-25 |
2020-09-02 |
애피바디 에이비 |
Abd 결합 폴리펩티드
|
|
EP2912051B1
(en)
|
2012-10-25 |
2018-04-18 |
Affibody AB |
Method for the separation of proteins containing an albumin-binding domain
|
|
WO2014076179A1
(en)
|
2012-11-14 |
2014-05-22 |
Affibody Ab |
New polypeptide
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
US9255262B2
(en)
*
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
EP2971290A4
(en)
*
|
2013-03-14 |
2017-03-01 |
The Governing Council Of The University Of Toronto |
Scaffolded peptidic libraries and methods of making and screening the same
|
|
CA2905186A1
(en)
|
2013-03-14 |
2014-09-18 |
Daiichi Sankyo Co., Ltd |
Novel binding proteins for pcsk9
|
|
CA2902657C
(en)
|
2013-03-15 |
2022-05-10 |
Affibody Ab |
Fcrn binding polypeptides
|
|
JP2016519108A
(ja)
|
2013-04-18 |
2016-06-30 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
インターロイキン−１０を疾病及び疾患の治療に用いる方法
|
|
WO2014204816A2
(en)
|
2013-06-17 |
2014-12-24 |
Armo Biosciences, Inc. |
Method for assessing protein identity and stability
|
|
PT3038633T
(pt)
|
2013-08-28 |
2021-01-14 |
Ipc Res Llc |
Polipéptidos estáveis que se ligam ao complemento humano c5
|
|
KR102497083B1
(ko)
|
2013-08-28 |
2023-02-07 |
애피바디 에이비 |
돌연변이된 스캐폴드를 갖는 결합 폴리펩티드
|
|
CA2920679A1
(en)
|
2013-08-30 |
2015-03-05 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
CN105848674A
(zh)
|
2013-11-11 |
2016-08-10 |
阿尔莫生物科技股份有限公司 |
将白细胞介素-10用于治疗疾病和病症的方法
|
|
WO2015091957A1
(en)
|
2013-12-20 |
2015-06-25 |
Affibody Ab |
Engineered albumin binding polypeptide
|
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
JP6704358B2
(ja)
|
2014-07-30 |
2020-06-03 |
エヌジーエム バイオファーマシューティカルズ インコーポレイテッド |
代謝障害を治療するための組成物および使用方法
|
|
US10323066B2
(en)
|
2014-09-17 |
2019-06-18 |
Affibody Ab |
Neonatal Fc receptor binding dimer and methods of use
|
|
CA2963989A1
(en)
|
2014-10-14 |
2016-04-21 |
Armo Biosciences, Inc. |
Interleukin-15 compositions and uses thereof
|
|
CN107106655A
(zh)
|
2014-10-22 |
2017-08-29 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素‑10治疗疾病和病症的方法
|
|
ES2799503T3
(es)
|
2014-10-31 |
2020-12-18 |
Ngm Biopharmaceuticals Inc |
Composiciones y procedimientos de uso para el tratamiento de trastornos metabólicos
|
|
KR20240110106A
(ko)
|
2015-01-12 |
2024-07-12 |
애피바디 에이비 |
Il-17a-결합 폴리펩티드
|
|
WO2016126615A1
(en)
|
2015-02-03 |
2016-08-11 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
EP3291828A4
(en)
|
2015-05-06 |
2018-10-03 |
Alborz Mahdavi |
Glucose responsive insulins
|
|
CN107847583A
(zh)
|
2015-05-28 |
2018-03-27 |
阿尔莫生物科技股份有限公司 |
用于治疗癌症的聚乙二醇化白细胞介素‑10
|
|
JP6882782B2
(ja)
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
|
|
EP3341012B1
(en)
|
2015-08-25 |
2025-07-30 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
CN107022031A
(zh)
*
|
2016-01-29 |
2017-08-08 |
中国人民解放军军事医学科学院微生物流行病研究所 |
融合蛋白HSA1-Vβ1及其应用
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
JP2020500150A
(ja)
|
2016-09-23 |
2020-01-09 |
デューク ユニバーシティ |
下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
|
|
CN107952080A
(zh)
*
|
2016-10-14 |
2018-04-24 |
中国科学院过程工程研究所 |
一种肿瘤靶向多肽-药物偶联衍生物、其制备方法及应用
|
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
|
US11077199B2
(en)
|
2017-08-09 |
2021-08-03 |
Massachusetts Institute Of Technology |
Albumin binding peptide conjugates and methods thereof
|
|
EP3691693A4
(en)
|
2017-10-06 |
2021-08-25 |
University Of Utah Research Foundation |
FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE
|
|
US20200239575A1
(en)
*
|
2017-10-06 |
2020-07-30 |
University Of Utah Research Foundation |
A fusion protein for targeted therapy of autoimmune disease
|
|
WO2019147954A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
JP7545894B2
(ja)
|
2018-03-13 |
2024-09-05 |
アフィボディ アクティエボラーグ |
新規足場に基づくポリペプチド
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
WO2020028806A1
(en)
|
2018-08-02 |
2020-02-06 |
Duke University |
Dual agonist fusion proteins
|
|
WO2020051541A1
(en)
*
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
EP3930687A4
(en)
|
2019-02-25 |
2023-06-07 |
The University of Chicago |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
|
|
MX2021014649A
(es)
|
2019-06-04 |
2022-01-06 |
Molecular Partners Ag |
Dominio de repetición de anquirina diseñado con estabilidad mejorada.
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
JP2022546525A
(ja)
|
2019-09-02 |
2022-11-04 |
ビオテスト・アクチエンゲゼルシャフト |
延長された半減期を有する第ｖｉｉｉ因子タンパク質
|
|
EP3785726A1
(en)
|
2019-09-02 |
2021-03-03 |
Biotest AG |
Factor viii protein with increased half-life
|
|
US20220389066A1
(en)
|
2019-11-05 |
2022-12-08 |
Affibody Ab |
Polypeptides
|
|
WO2021165226A1
(en)
|
2020-02-17 |
2021-08-26 |
Biotest Ag |
Subcutaneous administration of factor viii
|
|
EP3878515A1
(en)
*
|
2020-03-09 |
2021-09-15 |
Hober Biotech AB |
Therapeutic agent targeting her2
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
JP2023554258A
(ja)
|
2020-12-21 |
2023-12-27 |
アフィボディ アクティエボラーグ |
新規のポリペプチド
|
|
WO2022171892A1
(en)
|
2021-02-15 |
2022-08-18 |
Affibody Ab |
New her2-binding polypeptide
|
|
CN118632866A
(zh)
|
2022-02-08 |
2024-09-10 |
阿菲博迪公司 |
结合胸腺基质淋巴细胞生成素的蛋白质z变体及其医疗用途
|
|
KR20250005573A
(ko)
|
2022-05-18 |
2025-01-09 |
프로토머 테크놀로지스 인크. |
방향족 붕소-함유 화합물 및 관련 인슐린 유사체
|
|
KR20250047787A
(ko)
|
2022-08-10 |
2025-04-04 |
교와 가부시키가이샤 |
어피바디 미셀 약물 복합체
|
|
TW202448926A
(zh)
|
2023-02-17 |
2024-12-16 |
比利時商艾伯霖克斯公司 |
結合新生兒fc受體之多肽
|
|
WO2024227930A1
(en)
|
2023-05-04 |
2024-11-07 |
Affibody Ab |
New polypeptide
|
|
WO2025073871A1
(en)
|
2023-10-03 |
2025-04-10 |
Bicycletx Limited |
Bicyclic peptide ligand complexes specific for tfr1
|
|
WO2025158010A1
(en)
|
2024-01-25 |
2025-07-31 |
Affibody Ab |
Her2-binding polypeptide
|
|
CN118666961B
(zh)
*
|
2024-08-23 |
2024-11-26 |
通化安睿特生物制药股份有限公司 |
人白蛋白特异结合多肽及其应用
|